Assess a series of important considerations for comanagement of HIV/HCV infection and opioid use disorder (OUD), including the high level of compatibility between HIV and/or HCV treatment regimens and medications for the treatment of OUD, the impact of comorbid stimulant use among patients with OUD, recognition of OUD as a chronic relapsing disorder that often requires treatment reinitiation, and the challenges of pain management for individuals with OUD.
Sandra Springer, MD
Christian B. Ramers, MD, MPH
Released: February 6, 2020Expiration: No longer available for credit
This program is divided into several short segments which you can step through using the Video Chapters widget.
Expert HIV faculty analyze new data from CROI 2022, from Clinical Care Options (CCO)
Joseph J. Eron, Jr., MD
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN
Jasjit Gill, BSPharm, PharmD
1.0 Nursing contact hour Pharmacists:
1.0 contact hour (0.1 CEUs) Released: May 10, 2022Expired:
May 9, 2023